• ARMGO Pharma Receives FDA Orphan Drug Designation for ARM210 https://www.americanpharmaceuticalreview.com/1315-
    September 07, 2018
    ARMGO Pharma announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARM210 (also known as S48168), a potential treatment for patients with Ryanodine Receptor Type 1 Related ...
PharmaSources Customer Service